Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The OPuS One clinical study of 206 patients demonstrated improvement in pain relief1-2 and quality of life that was:
Unmatched commitment to the advancement of a minimally invasive therapy, and to thinking beyond the procedure
Discover Accurian™ 2.0, complete with responsive algorithms, efficient workflows, an easy-to-use interface, and many more features designed to save steps and time during procedures.
Levy J, David E, Hopkins T, et al. Radiofrequency ablation for the palliative treatment of osseous metastases: final results from a multicenter study (OPuS One). Abstract presented at the Society for Interventional Radiology Annual Scientific Meeting. Virtual. 2021.
Levy J, David E, Hopkins T, et al. Improvement in quality of life in patients treated for painful osseous metastases with radiofrequency ablation: The OPuS One Study. Abstract presented at the Society for Interventional Radiology Annual Scientific Meeting. Virtual. 2021.
Ong KL, Beall DP, Frohbergh M, Lau E, Hirsch JA, et al. Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials? Osteoporos Int. 2018;29(2):375–383. doi:10.1007/s00198-017-4281-z.
Lange A, Kasperk C, Alvares L, Sauermann S, Braun S. Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using German claims data. Spine. 2014;39(4): 318-326.
Edidin AA, Ong KL, Lau E, Kurtz SM. Morbidity and mortality after vertebral fractures: comparison of vertebral augmentation and non-operative management in the Medicare population. Spine. 2015;40(15):1228-1241.
Edidin AA, Ong KL, Lau E, Kurtz SM. Mortality risk for operated and non-operated vertebral fracture patients in the Medicare population. J Bone Miner Res. 2011;26(7):1617-1626.
McCullough BJ, Comstock BA, Deyo RA, Kreuter W, Jarvik JG. Major medical outcomes with spinal augmentation versus conservative therapy. JAMA Intern Med. 2013;173(16):1514-1521.
Chen AT, Cohen DB, Skolasky RL. Impact of nonoperative treatment, vertebroplasty, and kyphoplasty on survival and morbidity after vertebral compression fracture in the Medicare population. J Bone Joint Surg Am. 2013;95(19):1729-1736.
Boonen S, Van Meirhaeghe J, Bastian L, et al. Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2-year results from a randomized trial. J Bone Miner Res. 2011;26(7):1627-1637.
Pre-ablation worst pain was 8.2 decreasing to 5.6 (n=94) at 3 days, 4.7 (n=89) at 1 week, 3.9 (n=64) at 1 month, 3.7 (n=46) at 3 months, and 3.5 (n=22) at 6 months. P<0.0001 all visits.